Epitomics competitors

Paul Grayson is a Board of Directors at Bird Rock Bio Inc, Managing Director at AccessBioVentures, and Partner at Versant Ventures and is based in San Diego, California. He has worked as Board Member at Naviscan Inc; Managing Director at Sanderling Ventures; and Senior Vice President, Corporate Development at Aurora BioScience. Paul works or has worked as Board Member at ALEXION PHARMACEUTICALS, INC.; Investment Professional at Versant Ventures; and Board Member at Anaphore. He attended UCLA between 1984 and 1987, Paul Merage School of Business between 1989 and 1991, and University of California Irvine between 1989 and 1991.

Carin Mueller Rollins is Founder & CEO of Hinge Bio, Inc. She has been involved in the biotech field for nearly 25 years and has a unique mix of experience in venture capital, management consulting and equity research. Carin was previously co-founder of 5AM Ventures, an early-stage life science venture fund, where she specialized in company creation efforts and was founding Board Member of Marcadia (sold to Roche in 2011) and KaloBios (IPO in 2013). She also was an Investment Manager with Bay City Capital, an Associate in the pharmaceuticals practice of Booz Allen & Hamilton and an Equity Research Associate with the investment bank Robertson Stephens & Company. Carin holds a B.A. in Biology from Colgate University, where she served as a Trustee, and an MBA from the Stanford Graduate School of Business.